Synchrony upgraded to Outperform from Market Perform at Keefe Bruyette

Keefe Bruyette upgraded Synchrony to Outperform from Market Perform with a price target of $62, up from $45. The analyst believes much of the uncertainty related to the late fee regulation is diminishing along with recent positive developments on the court front for private label issuers. When the firm incorporates conservative assumptions, it still gets to significant upside potential from current levels for the stock that compensates investors enough for the associated risks.